---
title: "HANDLER: Signed the Termination of Equity Acquisition Cooperation Agreement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263453560.md"
description: "Handler announced that the company, Changsha Zhenghao, and Hunan Huaxun signed a termination cooperation \"Agreement\" on October 29, 2025. Due to the parties' failure to reach a consensus on key terms of the acquisition, it was mutually agreed to terminate the signed \"Equity Acquisition Cooperation Agreement.\" This termination of cooperation will not affect the company's normal operations and will not impact the company's future development plans"
datetime: "2025-10-30T08:11:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263453560.md)
  - [en](https://longbridge.com/en/news/263453560.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263453560.md)
generator: "portal-rs"
---

# HANDLER: Signed the Termination of Equity Acquisition Cooperation Agreement

HANDLER announced that the company, Changsha Zhenghao, and Hunan Huaxun signed a termination cooperation "Agreement" on October 29, 2025. Due to the parties' failure to reach a consensus on key terms of the acquisition, it was mutually agreed to terminate the signed "Equity Acquisition Cooperation Agreement." This termination of cooperation will not affect the company's normal operations and will not impact the company's future development plans

### Related Stocks

- [300201.CN](https://longbridge.com/en/quote/300201.CN.md)

## Related News & Research

- [FTON: Strong revenue and profit growth in H1 2026, with strategic expansion and solid outlook](https://longbridge.com/en/news/297125712.md)
- [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md)
- [Li Auto: Sequential revenue growth and strong cash position offset margin pressure from higher input costs](https://longbridge.com/en/news/297063840.md)
- [Sappi, UPM propose graphic paper joint venture](https://longbridge.com/en/news/297161466.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**